Navigation Links
Dynatronics Announces Increases in Pre-tax Profits and Net Income for the Quarter Ended December 31, 2009
Date:1/13/2010

SALT LAKE CITY, Jan. 13 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) expects increases in pre-tax profits and net income for the quarter ended December 31, 2009.  Final results will be announced in the next few weeks.

Higher than expected sales in the month of December combined with reductions in expenses support the company's expectations of pre-tax profits in the range of $275,000 to $300,000 for the quarter ended December 31, 2009 compared to pre-tax profits of $89,917 for the quarter ended December 31, 2008.  Net income is expected to be approximately $170,000 to $185,000 for the quarter ended December 31, 2009 compared to net income of $54,598 for the quarter ended December 31, 2008.

"The second quarter is typically a strong sales and profit quarter for the company, but this exceeded our expectations," said Kelvyn H. Cullimore, chairman and president of Dynatronics. "Given the ongoing challenges to economic growth in the United States this increase in profitability over last year is very gratifying and indicative of improved operating efficiencies along with increased sales of high margin capital equipment."

"Looking ahead, we anticipate continued improvement in sales and net income from the expansion of our direct sales force and the preferred vendor agreements with large chains of clinics which were recently announced," added Cullimore.  "Our velocity continues to increase in a positive direction, and we expect this trend to continue."

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.

This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements such as the statement regarding  increases in pre-tax profits and net income for the quarter ended December 31, 2009 and the expectation for continued improvement in sales and net income from the expansion of the company's direct sales force and the preferred vendor agreements with large chains of clinics.  Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost effective rates, and the risk factors listed from time to time in the company's SEC reports including, but not limited to, the report on Form 10-K for the year ended June 30, 2009.

SOURCE Dynatronics Corporation

RELATED LINKS
http://www.dynatronics.com

'/>"/>

SOURCE Dynatronics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics Inks Preferred Vendor Agreement with 1,100 Member Preferred Therapy Providers, Inc.
2. Dynatronics Receives 180-Day NASDAQ Extension
3. Dynatronics Named Sole-Source Supplier to Benchmark Physical Therapy
4. Dynatronics Announces Positive Financial Results for Quarter
5. Dynatronics to Release First Quarter Results Friday, November 13, 2009; Conference Call Set for 1:30 p.m. ET
6. Dynatronics Will Request Hearing With Nasdaq Regarding Listing Status
7. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
8. The Foundry Announces Completion of Series A Financing for Twelfth Company
9. DATATRAK International, Inc. Announces Year-End Backlog
10. Stryker Corporation Announces Pricing of Senior Notes
11. Sarnova Announces Acquisition of CVC, Inc. to Expand Portfolio of Specialty Medical Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... , January 13, 2017 This ... see how they have fared at yesterday,s closing bell: ... Biopharma Inc. (NASDAQ: GALE ), and ACADIA ... harness cellular and biomolecular processes to develop technologies and ... environmental footprint, feed the hungry, use less and cleaner ...
(Date:1/13/2017)... 2017 The 2016 election resulted in ... states voting in favor of legalizing cannabis for recreational use, ... in the U.S. In addition, the state of ... cannabis products sales. The ArcView Group has published an updated ... cannabis sales in the U.S. last year reached $6.7 billion, a ...
(Date:1/13/2017)... 2017   JDRF , the leading global ... pleased to announce that after more than a ... & Medicaid Services (CMS) has recognized continuous glucose ... use in making diabetes treatment decisions as durable ... eligible for coverage under Medicare. JDRF has been ...
Breaking Medicine Technology:
(Date:1/16/2017)... New York (PRWEB) , ... January 16, 2017 ... ... SightMD today announced the addition of Victor Giamos, MD to their ... of SightMD and Managing Partner at North Shore Eye Care, a division of ...
(Date:1/16/2017)... , ... January 16, 2017 , ... ... availability of the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol ... protocols to understand the scope of their EHS regulatory obligations and rapidly collect, ...
(Date:1/16/2017)... ... ... St. Louisans are well-aware of the following facts at present:, ... be having no effect on keeping this particularly bad strain of the flu away , ... sneezing, or sniffling , These facts are well-known among the team at ...
(Date:1/16/2017)... Beverly Hills, CA (PRWEB) , ... January 16, ... ... published a manuscript in the Aesthetic Surgery Journal , the official journal ... study he conducted on lower eyelid retraction surgery. The procedure is designed to ...
(Date:1/16/2017)... ... January 16, 2017 , ... One thing common to all types ... to test for, as well. The money spent screening for and treating cancer in ... U.S. screen patients for cancer more than in any other country that has an ...
Breaking Medicine News(10 mins):